LiTime Debuts at ISC West 2026, Showcasing Lithium Battery Solutions for Security Power Systems

LiTime, a leading LiFePO4 battery manufacturer, showcased its latest lithium energy solutions for security system batteries and surveillance system applications at ISC West 2026 in Las Vegas this ...
pharmaphorum

BMS strikes again, with $4.1bn RayzeBio takeover bid

Bristol-Myers Squibb is having a busy holiday period, signing a $4.1 billion deal to acquire cancer drug developer RayzeBio – its second multibillion-dollar M&A deal in the space of a week. BMS is ...
pharmaphorum

BMS gets FDA approval for Krazati in colorectal cancer

Bristol-Myers Squibb’s KRAS inhibitor Krazati has been approved for a second indication, colorectal cancer (CRC), which could inject some much-needed sales growth into the product. The FDA has given ...
Nature

Bristol-Myers Squibb swallows last of antibody pioneers

The impending merger between Bristol-Myers Squibb (BMS) and Medarex marks the end of an era. Medarex is one of the last independent public biotech companies that built their businesses around ...
IEEE

Bms Fusa –How to Achieve Fusa Compliance for A Wireless Bms Design

Abstract: The current trends in automotive development show that the use of wireless technology becomes more and more relevant. In battery development, this wireless technology can be applied to ...
IEEE

Characterization of the Susceptibility to EMI of a BMS IC for Electric Vehicles by Direct Power and Bulk Current Injection

Abstract: In this letter the susceptibility to Electromagnetic Interference of a Battery Management System for Lithium-Ion and Lithium Polymer battery packs employed in emerging electric and hybrid ...